BASF SE BASFY recently inaugurated the expansion of its Alkyl Polyglucosides (APG) production facility at its Bangpakong site in Thailand. This marks a significant step in its strategy to bolster regional manufacturing capacity for sustainable surfactants in Asia.
The expansion is aimed at strengthening BASF’s supply capabilities in one of its key growth geographies. By adding this plant in Thailand, the company is aiming to serve its customers across personal care, home care and industrial sectors with greater agility and flexibility.
Global APG Production Footprint Expansion
This facility in Bangpakong complements BASF’s global APG production footprint, which already includes sites in Düsseldorf (Germany), Jinshan (China), and Cincinnati (USA). The company also mentioned that a new APG production line in Cincinnati is scheduled to come online in 2026.
APGs are bio-based and readily biodegradable surfactants, derived from 100% natural, renewable feedstocks. Because they are non-ionic, they can blend well with other surfactants, making them versatile for a wide range of applications.
In a broader context, this investment aligns with an earlier announcement by BASF back in June 2023, in which the company proposed expanding APG capacity both in Bangpakong and in Cincinnati. That earlier plan framed the expansion as a way to reduce cross-regional volume flows and enhance responsiveness to local markets.
The inauguration of this plant underscores BASF’s long-term commitment to sustainable surfactant chemistry and its intention to maintain a strong, regionally balanced footprint. By localizing production closer to its Asian customer base, BASF is positioning itself to respond more quickly to market growth and evolving demands for green, bio-based chemical solutions.
Shares of BASFY are up 16% year to date against its industry’s 28.3% decline.
Image Source: Zacks Investment Research BASFY’s Zacks Rank & Key Picks
BASFY currently carries a Zacks Rank of #3 (Hold).
Some better-ranked stocks in the Basic Materials space are AngloGold Ashanti Plc. AU, Franco-Nevada Corporation FNV and CSW Industrials, Inc. CSW. AU sports a Zacks Rank of #1 (Strong Buy) while FNV and CSW carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for AU’s current fiscal-year earnings is pegged at $5.71 per share, indicating a 159% year-over-year increase. The consensus estimate has been trending higher over the past 60 days.
The Zacks Consensus Estimate for FNV’s current fiscal-year earnings is pegged at $5.13 per share, indicating a 60% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 7.7%.
The Zacks Consensus Estimate for CSW’s current fiscal-year earnings is pegged at $10.4 per share, indicating a 24% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 7%.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They include
Stock #1: A Disruptive Force with Notable Growth and Resilience
Stock #2: Bullish Signs Signaling to Buy the Dip
Stock #3: One of the Most Compelling Investments in the Market
Stock #4: Leader In a Red-Hot Industry Poised for Growth
Stock #5: Modern Omni-Channel Platform Coiled to Spring
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.
Download Atomic Opportunity: Nuclear Energy's Comeback free today.BASF SE (BASFY) : Free Stock Analysis Report
AngloGold Ashanti PLC (AU) : Free Stock Analysis Report
Franco-Nevada Corporation (FNV) : Free Stock Analysis Report
CSW Industrials, Inc. (CSW) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.